Aquestive Therapeutics, Inc.
SEC CIK 1398733 · AQST · last insider filing 2026-06-24
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Krop Julie | Director | filed 2021 - 2026 |
| Barber Daniel | Director · SVP-Chief Strategy/Dev Officer | filed 2018 - 2026 |
| Morris Timothy E | Director | filed 2022 - 2026 |
| Brown Gregory B | Director | filed 2018 - 2026 |
| Cochran John | Director | filed 2018 - 2026 |
| Taglietti Marco | Director | filed 2021 - 2026 |
| Jenkins Abigail L. | Director | filed 2024 - 2026 |
| Bratton Douglas K | Director | filed 2018 - 2024 |
| Schobel Alexander Mark | Director · SVP,Chief Innov/Tech Officer | filed 2018 - 2024 |
| Costa Santo J | Director | filed 2018 - 2024 |
| Kendall Keith J | Director · President and CEO | filed 2018 - 2022 |
| Scibetta James S | Director | filed 2018 - 2021 |
| Lurker Nancy | Director | filed 2018 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Korczynski Sherry | SVP Sales and Marketing | filed 2024 - 2026 |
| Zalewski Thomas A. | Chief Legal Officer | filed 2026 - 2026 |
| Cioffi Melina | SVP, Regulatory Affairs | filed 2025 - 2026 |
| Braender Lori J | SVP, General Counsel | filed 2018 - 2026 |
| Toth A Ernest JR | SVP, Chief Financial Officer | filed 2021 - 2026 |
| Boyd Peter E. | See Remarks | filed 2018 - 2026 |
| Jung Cassie | SVP, Operations | filed 2023 - 2026 |
| Davis Matthew W. | Chief Development Officer | filed 2025 - 2026 |
| Greenhawt Matthew J. | Chief Medical Officer | filed 2026 - 2026 |
| Kraus Carl N | Chief Medical Officer | filed 2023 - 2025 |
| Wargacki Stephen | SVP, Research & Development | filed 2023 - 2025 |
| Marshall Ken W. | SVP, Chief Commercial Officer | filed 2018 - 2023 |
| Truitt Kenneth | Chief Medical Officer | filed 2022 - 2022 |
| Wood Theresa | SVP-HR and Org. Development | filed 2018 - 2022 |
| Maxwell John T. | SVP-Chief Financial Officer | filed 2018 - 2020 |
| Slatko Gary H | SVP, Chief Medical Officer | filed 2019 - 2020 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.